Synonym: PC; (7R)-4-Hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxohexadecyl)oxy]- 3,5,9-trioxa-4-phosphapentacosan-1-aminium 4-oxide, inner salt; 1,2-Dihexadecanoyl-sn-glycero-3-phosphocholine; 1,2-Dihexadecanoyl-sn-glycero-3-phosphorylcholine; 1,2-Dipalmitoyl-sn-glycero-3-phosphorylcholine; 1,2-Dipalmitoyl-L-lecithin; L-α-Phosphatidylcholine, dipalmitoyl; L-β,γ-Dipalmitoyl-α-lecithin; DPPC; PC(16:0/16:0)
CAS Number: 63-89-8
Empirical Formula (Hill Notation): C40H80NO8P
Molecular Weight: 734.04
EC Number: 200-567-6
MDL Number: MFCD00036903
Linear Formula: C40H80NO8P
Product Type: Chemical
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts SKU: P0763-100MG
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts SKU: P0763-1G
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts SKU: P0763-250MG
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts SKU: P0763-50MG
This picture is provided solely for illustration purposes. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts SKU: P0763-5G
| assay |
≥99% |
| biological source |
semisynthetic |
| form |
powder |
| functional group |
phospholipid |
| InChI |
1S/C40H80NO8P/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-39(42)46-36-38(37-48-50(44,45)47-35-34-41(3,4)5)49-40(43)33-31-29-27-25-23-21-19-17-15-13-11-9-7-2/h38H,6-37H2,1-5H3/t38-/m1/s1 |
| InChI key |
KILNVBDSWZSGLL-KXQOOQHDSA-N |
| lipid type |
phosphoglycerides |
| Quality Level |
200  |
| shipped in |
ambient |
| SMILES string |
[O-]P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(CCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCC)=O)=O |
| storage temp. |
−20°C |
| Application: |
- Effects induced by η(6)-p-cymene ruthenium(II) complexes on Langmuir monolayers mimicking cancer and healthy cell membranes do not correlate with their toxicity.: This study explores the impact of η(6)-p-cymene ruthenium(II) complexes on Langmuir monolayers, including 1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), to model cancer and healthy cell membranes, revealing insights into membrane interactions and cytotoxicity mechanisms (Wrobel et al., 2024
 ). - Interaction of L-phenylalanine with carbonyl groups in mixed lipid membranes.: This research examines the interaction of L-phenylalanine with carbonyl groups in mixed lipid membranes, incorporating DPPC, to understand the role of amino acids in membrane dynamics and stability (Brandan et al., 2024
 ). - Spatial Arrangement of the Drug Ibuprofen in a Model Membrane in the Presence of Lipid Rafts.: The study investigates the spatial arrangement of ibuprofen within a model membrane containing lipid rafts, with DPPC as a component, shedding light on drug-membrane interactions and the role of lipid rafts in drug delivery (Kashnik et al., 2024
 ).
|
| Packaging: |
1, 5 g in poly bottle |
| Packaging: |
50, 100, 250 mg in poly bottle |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥99% |
| Storage Temp. |
−20°C |
| UNSPSC |
12352211 |